Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan-Dirk Studt

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|May 6, 2021
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validationGuido Willekens, Jan-Dirk Studt, Adriana Mendez, et al.
Thrombosis Research|March 27, 2017
Impact of rivaroxaban on point-of-care assaysPierre Fontana, Lorenzo Alberio, Anne Angelillo-Scherrer, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 2, 2024
Plasma and platelet lipidome changes in Fabry diseaseBo Burla, Jeongah Oh, Albina Nowak, et al.
Frontiers in Cardiovascular Medicine|September 27, 2021
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban MeasurementsTamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, et al.
Diagnostics (Basel, Switzerland)|June 28, 2023
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban CalibratorAnnika Burger, Jan-Dirk Studt, Adriana Mendez, et al.
Frontiers in Cardiovascular Medicine|April 4, 2022
Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional StudyTamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, et al.
Basic Research in Cardiology|October 12, 2012
Dronedarone reduces arterial thrombus formationAlexander Breitenstein, Susanna H M Sluka, Alexander Akhmedov, et al.
Blood Advances|August 4, 2025
Outcomes of Patients with Suspected Heparin-Induced Thrombocytopenia in a Contemporary Multicenter CohortHenning Nilius, Ekaterina Sinitsa, Jan-Dirk Studt, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2023
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT studyAngelika Hammerer-Lercher, Henning Nilius, Jan-Dirk Studt, et al.
Journal of Thrombosis and Haemostasis : JTH|November 13, 2024
The dynamic range of immunoassays for heparin-induced thrombocytopeniaHenning Nilius, Samra Naas, Jan-Dirk Studt, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|May 6, 2021
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validationGuido Willekens, Jan-Dirk Studt, Adriana Mendez, et al.
Thrombosis Research|March 27, 2017
Impact of rivaroxaban on point-of-care assaysPierre Fontana, Lorenzo Alberio, Anne Angelillo-Scherrer, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 2, 2024
Plasma and platelet lipidome changes in Fabry diseaseBo Burla, Jeongah Oh, Albina Nowak, et al.
Frontiers in Cardiovascular Medicine|September 27, 2021
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban MeasurementsTamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, et al.
Diagnostics (Basel, Switzerland)|June 28, 2023
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban CalibratorAnnika Burger, Jan-Dirk Studt, Adriana Mendez, et al.
Frontiers in Cardiovascular Medicine|April 4, 2022
Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional StudyTamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, et al.
Basic Research in Cardiology|October 12, 2012
Dronedarone reduces arterial thrombus formationAlexander Breitenstein, Susanna H M Sluka, Alexander Akhmedov, et al.
Blood Advances|August 4, 2025
Outcomes of Patients with Suspected Heparin-Induced Thrombocytopenia in a Contemporary Multicenter CohortHenning Nilius, Ekaterina Sinitsa, Jan-Dirk Studt, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2023
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT studyAngelika Hammerer-Lercher, Henning Nilius, Jan-Dirk Studt, et al.
Journal of Thrombosis and Haemostasis : JTH|November 13, 2024
The dynamic range of immunoassays for heparin-induced thrombocytopeniaHenning Nilius, Samra Naas, Jan-Dirk Studt, et al.
Pageof 6